FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2175145114> ?p ?o ?g. }

• W2175145114 endingPage "115.e2" @default.
• W2175145114 startingPage "110" @default.
• W2175145114 abstract "Purpose To describe the outcome in children of eyes with uveitis following repeated treatment with dexamethasone (Ozurdex) implants. Design Retrospective, interventional study. Methods Twenty-two eyes of 16 pediatric patients with uveitis were treated with 35 dexamethasone implants at a tertiary referral center. Following implantations, anatomic and functional outcomes, as well as ocular complications, were noted. Main outcome measures included best-corrected visual acuity, central retinal thickness, number and dosage of systemic immunosuppression drugs, vitreous haze score, and presence of raised intraocular pressure or cataract. Results Following the first implantation, average best-corrected visual acuity improved significantly from 0.55 ± 0.08 logMAR to 0.37 ± 0.08 logMAR (P = .024), central retinal thickness decreased by 219 ± 55 μm (P = .01), and the percentage of eyes achieving a vitreous haze score of 0 increased from 41% to 88% (P = .006). The median time to relapse following the first injection was 9 months, with a similar response achieved after each repeat implantation. Children previously requiring systemic immunosuppression at the time of the first implantation were able to stop or significantly reduce the dose and number of drugs. In total there were 4 instances of cataract progression that were not visually significant and did not require surgical treatment and 6 cases of raised IOP, 5 of which were treated pharmacologically with no surgical intervention required and 1 that required revision of a previous filtration surgery. There were no cases of implant migration into the anterior chamber, endophthalmitis, or retinal detachment. Conclusions The use of dexamethasone implants in children results in improved retinal thickness and reduction in ocular inflammation, which can improve vision for several months. Repeat implantations result in continued control of the inflammation, allowing for reduction of systemic immunosuppression with few ocular complications. To describe the outcome in children of eyes with uveitis following repeated treatment with dexamethasone (Ozurdex) implants. Retrospective, interventional study. Twenty-two eyes of 16 pediatric patients with uveitis were treated with 35 dexamethasone implants at a tertiary referral center. Following implantations, anatomic and functional outcomes, as well as ocular complications, were noted. Main outcome measures included best-corrected visual acuity, central retinal thickness, number and dosage of systemic immunosuppression drugs, vitreous haze score, and presence of raised intraocular pressure or cataract. Following the first implantation, average best-corrected visual acuity improved significantly from 0.55 ± 0.08 logMAR to 0.37 ± 0.08 logMAR (P = .024), central retinal thickness decreased by 219 ± 55 μm (P = .01), and the percentage of eyes achieving a vitreous haze score of 0 increased from 41% to 88% (P = .006). The median time to relapse following the first injection was 9 months, with a similar response achieved after each repeat implantation. Children previously requiring systemic immunosuppression at the time of the first implantation were able to stop or significantly reduce the dose and number of drugs. In total there were 4 instances of cataract progression that were not visually significant and did not require surgical treatment and 6 cases of raised IOP, 5 of which were treated pharmacologically with no surgical intervention required and 1 that required revision of a previous filtration surgery. There were no cases of implant migration into the anterior chamber, endophthalmitis, or retinal detachment. The use of dexamethasone implants in children results in improved retinal thickness and reduction in ocular inflammation, which can improve vision for several months. Repeat implantations result in continued control of the inflammation, allowing for reduction of systemic immunosuppression with few ocular complications." @default.
• W2175145114 created "2016-06-24" @default.
• W2175145114 creator A5016800738 @default.
• W2175145114 creator A5029590686 @default.
• W2175145114 creator A5055970039 @default.
• W2175145114 creator A5059361239 @default.
• W2175145114 creator A5069797418 @default.
• W2175145114 date "2016-01-01" @default.
• W2175145114 modified "2023-10-17" @default.
• W2175145114 title "Outcome of Treating Pediatric Uveitis With Dexamethasone Implants" @default.
• W2175145114 cites W1551296378 @default.
• W2175145114 cites W1719749797 @default.
• W2175145114 cites W1975590262 @default.
• W2175145114 cites W1986408411 @default.
• W2175145114 cites W1994243439 @default.
• W2175145114 cites W2006829533 @default.
• W2175145114 cites W2017575727 @default.
• W2175145114 cites W2047008569 @default.
• W2175145114 cites W2056287065 @default.
• W2175145114 cites W2058660748 @default.
• W2175145114 cites W2068789854 @default.
• W2175145114 cites W2071162479 @default.
• W2175145114 cites W2081662709 @default.
• W2175145114 cites W2096319720 @default.
• W2175145114 cites W2123008745 @default.
• W2175145114 cites W2126614009 @default.
• W2175145114 cites W2138598379 @default.
• W2175145114 cites W2150335931 @default.
• W2175145114 cites W2154980334 @default.
• W2175145114 doi "https://doi.org/10.1016/j.ajo.2015.09.036" @default.
• W2175145114 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26478217" @default.
• W2175145114 hasPublicationYear "2016" @default.
• W2175145114 type Work @default.
• W2175145114 sameAs 2175145114 @default.
• W2175145114 citedByCount "29" @default.
• W2175145114 countsByYear W21751451142016 @default.
• W2175145114 countsByYear W21751451142017 @default.
• W2175145114 countsByYear W21751451142018 @default.
• W2175145114 countsByYear W21751451142019 @default.
• W2175145114 countsByYear W21751451142020 @default.
• W2175145114 countsByYear W21751451142021 @default.
• W2175145114 countsByYear W21751451142022 @default.
• W2175145114 countsByYear W21751451142023 @default.
• W2175145114 crossrefType "journal-article" @default.
• W2175145114 hasAuthorship W2175145114A5016800738 @default.
• W2175145114 hasAuthorship W2175145114A5029590686 @default.
• W2175145114 hasAuthorship W2175145114A5055970039 @default.
• W2175145114 hasAuthorship W2175145114A5059361239 @default.
• W2175145114 hasAuthorship W2175145114A5069797418 @default.
• W2175145114 hasConcept C118487528 @default.
• W2175145114 hasConcept C126322002 @default.
• W2175145114 hasConcept C141071460 @default.
• W2175145114 hasConcept C167135981 @default.
• W2175145114 hasConcept C2776194053 @default.
• W2175145114 hasConcept C2777235844 @default.
• W2175145114 hasConcept C2778257484 @default.
• W2175145114 hasConcept C2780401358 @default.
• W2175145114 hasConcept C2780428090 @default.
• W2175145114 hasConcept C2780827179 @default.
• W2175145114 hasConcept C2781092963 @default.
• W2175145114 hasConcept C2781411149 @default.
• W2175145114 hasConcept C71924100 @default.
• W2175145114 hasConceptScore W2175145114C118487528 @default.
• W2175145114 hasConceptScore W2175145114C126322002 @default.
• W2175145114 hasConceptScore W2175145114C141071460 @default.
• W2175145114 hasConceptScore W2175145114C167135981 @default.
• W2175145114 hasConceptScore W2175145114C2776194053 @default.
• W2175145114 hasConceptScore W2175145114C2777235844 @default.
• W2175145114 hasConceptScore W2175145114C2778257484 @default.
• W2175145114 hasConceptScore W2175145114C2780401358 @default.
• W2175145114 hasConceptScore W2175145114C2780428090 @default.
• W2175145114 hasConceptScore W2175145114C2780827179 @default.
• W2175145114 hasConceptScore W2175145114C2781092963 @default.
• W2175145114 hasConceptScore W2175145114C2781411149 @default.
• W2175145114 hasConceptScore W2175145114C71924100 @default.
• W2175145114 hasLocation W21751451141 @default.
• W2175145114 hasLocation W21751451142 @default.
• W2175145114 hasOpenAccess W2175145114 @default.
• W2175145114 hasPrimaryLocation W21751451141 @default.
• W2175145114 hasRelatedWork W1491585366 @default.
• W2175145114 hasRelatedWork W2072975542 @default.
• W2175145114 hasRelatedWork W2112951629 @default.
• W2175145114 hasRelatedWork W2255216093 @default.
• W2175145114 hasRelatedWork W2392620202 @default.
• W2175145114 hasRelatedWork W2505001290 @default.
• W2175145114 hasRelatedWork W3028849207 @default.
• W2175145114 hasRelatedWork W3030283649 @default.
• W2175145114 hasRelatedWork W3128741495 @default.
• W2175145114 hasRelatedWork W4384944007 @default.
• W2175145114 hasVolume "161" @default.
• W2175145114 isParatext "false" @default.
• W2175145114 isRetracted "false" @default.
• W2175145114 magId "2175145114" @default.
• W2175145114 workType "article" @default.